<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04830163</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00000896</org_study_id>
    <nct_id>NCT04830163</nct_id>
  </id_info>
  <brief_title>Phase-dependent PCMS in Chronic Stroke</brief_title>
  <official_title>Upregulating Corticospinal Function After Stroke Using Phase-dependent Paired Corticomotoneuronal Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas at Austin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas at Austin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After stroke, people often have difficulty using their hands. Combined brain and nerve&#xD;
      stimulation can strengthen the neural pathways that control hand function. In this study, we&#xD;
      will deliver combined brain and nerve stimulation during specific time windows that increase&#xD;
      activation of neural pathways underlying hand function. We will compare the effects of&#xD;
      combined brain and nerve stimulation during these optimal time windows to the effects of&#xD;
      combined brain and nerve stimulation applied during random time windows on post-stroke hand&#xD;
      function.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2024</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum hand force output</measure>
    <time_frame>up to 1 hour after intervention</time_frame>
    <description>This will be measured using maximum voluntary contractions of the stroke-affected first dorsal interosseous hand muscle during pinching actions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum hand muscle activation</measure>
    <time_frame>up to 1 hour after intervention</time_frame>
    <description>This will be measured using electromyography recordings of the stroke-affected first dorsal interosseous muscle during maximum voluntary contractions during pinching actions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amplitude of motor evoked potentials</measure>
    <time_frame>up to 1 hour after intervention</time_frame>
    <description>This will be measured as the peak-to-peak amplitude of motor-evoked potentials recorded from the stroke-affected first dorsal interosseous muscle</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Paired corticomotoneuronal stimulation during sensorimotor mu rhythm trough phases</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Paired corticomotoneuronal stimulation during random sensorimotor mu rhythm phases</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Phase-dependent paired corticomotoneuronal stimulation (PCMS)</intervention_name>
    <description>Paired corticomotoneuronal stimulation (PCMS) involves delivering precisely timed pairs of transcranial magnetic stimulation (TMS) and peripheral nerve stimulation (PNS) so that the neuronal activity evoked by such stimulation arrives synchronously at corticospinal-motoneuronal synapses. This synchronous arrival is postulated to cause long-term potentiation via spike timing-dependent plasticity, which then improves corticospinal transmission and hand function. In this study, paired corticomotoneuronal stimulation (PCMS) will be applied during specific brain states that reflect increased recruitment of motoneurons via the corticospinal tract. This increased recruitment is expected to enhance the beneficial effects of PCMS on human hand function after stroke.</description>
    <arm_group_label>Paired corticomotoneuronal stimulation during random sensorimotor mu rhythm phases</arm_group_label>
    <arm_group_label>Paired corticomotoneuronal stimulation during sensorimotor mu rhythm trough phases</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  History of stroke &gt; 6 months ago&#xD;
&#xD;
          -  Presence of residual upper extremity hemiparesis&#xD;
&#xD;
          -  Willingness to participate&#xD;
&#xD;
          -  Ability to provide informed consent&#xD;
&#xD;
          -  Upper extremity Fugl-Meyer score &lt; 66&#xD;
&#xD;
          -  Mini Mental State Exam score ≥ 24&#xD;
&#xD;
          -  Discernible and reliable MEP elicited following single-pulse TMS to the lesioned&#xD;
             hemisphere&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of neurological disease other than stroke&#xD;
&#xD;
          -  Presence of contraindications to transcranial magnetic stimulation (TMS) or peripheral&#xD;
             nerve stimulation (PNS), including:&#xD;
&#xD;
        history of adverse reactions to TMS or PNS metal in head, eyes, neck, chest/trunk, or arms,&#xD;
        including but not limited to shrapnel, surgical clips, fragments from metalworking,&#xD;
        fragments from welding implanted devices history of frequent and severe headaches or&#xD;
        migraines immediate family history of seizure or epilepsy personal history of seizure or&#xD;
        epilepsy current, suspected, or planned pregnancy current or recent (within the last 3&#xD;
        months) use of medications acting on the central nervous system other than selective&#xD;
        serotonin reuptake inhibitors (SSRIs), including but not limited to antipsychotic drugs,&#xD;
        benzodiazepines, prescription stimulants&#xD;
&#xD;
          -  Upper extremity Fugl-Meyer score ≥ 66 (66 is the maximum on this scale)&#xD;
&#xD;
          -  Mini Mental State Exam score &lt; 24 No discernible and reliable MEP elicited following&#xD;
             single-pulse TMS to the lesioned hemisphere&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Texas at Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78712</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Sara Hussain</last_name>
      <phone>512-232-2686</phone>
      <email>sara.hussain@austin.utexas.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 31, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic, movement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Individual participant data may be shared using an open-access data repository. No personally-identifiable information will be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

